Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array

Publication Type:

Journal Article

Source:

Pharm Res, Volume 28, Number 1, pp. 145-158 (2011)

ISBN:

0724-8741

DOI Name (links to online publication)

10.1007/s11095-010-0093-y

Keywords:

cholera toxin; diphtheria toxoid; microneedle array; transcutaneous immunization; vesicles; transdermal drug-delivery; dendritic cells; in-vivo; human skin; lymph-node; vaccine delivery; rigid vesicles; transport; carriers; penetration

Abstract:

Purpose To determine the immunogenicity of diphtheria toxoid (DT) formulated in two types of vesicles following transcutaneous immunization (TCI) of mice onto microneedle array-treated skin.Methods DT-containing cationic liposomes or anionic surfactant-based vesicles were prepared by extrusion and sonication. The physicochemical properties were characterized in terms of size, zeta-potential, vesicle elasticity and antigen association. TCI was performed by applying formulations onto intact or microneedle array-pretreated mice skin, using cholera toxin as an adjuvant. Subcutaneous and intradermal immunizations were as control. Immune responses were evaluated by IgG and neutralizing antibody titers, and the immune-stimulatory properties were assessed using cultured dendritic cells.Results Stable DT-containing cationic liposomes (similar to 150 nm) and anionic vesicles (similar to 100 nm) were obtained. Incorporation of Span 80 increased liposome elasticity. About 90% and 77% DT was associated with liposomes and vesicles, respectively. TCI of all formulations resulted in substantial antibody titers only if microneedle pretreatment was applied. Co-administration of cholera toxin further augmented the immune responses of TCl. However, vesicle formulations didn't enhance the immunogenicity on either intact or microneedle-treated skin and showed low stimulatory activity on dendritic cells.Conclusions Microneedle pretreatment and cholera toxin, but not antigen association to vesicles, enhances the immunogenicity of topically applied DT.

22/08/2012